5
Table 2. Assessment of ASCVD Risk in Patients with
Endocrine Diseases
Suggested Steps in Risk Assessment
Determine if the patient has established ASCVD or long-standing diabetes. If not,
proceed with risk assessment.
Calculate 10-year risk using the Pooled Cohort Equations
(http://static.heart.org/riskcalc/app/index.html#!/baseline-risk)
Assess for presence of additional risk enhancing factors.
e Endocrine Society considers persistent Cushing syndrome and Cushing disease,
high dose chronic glucocorticoid therapy, and possibly adult GHD, acromegaly, and
hypothyroidism as risk enhancing factors.
In borderline to intermediate risk patients (10-year ASCVD risk 5%–19.9%) consider a
CAC score, particularly when risk enhancing factors are present.
Conduct a clinician-patient risk discussion, including discussion of lifetime risk and
lifetime lipid-lowering treatment benefit, along with patient preferences.
